DJIA 16,804.71 -238.19 -1.40%
NASDAQ 4,422.09 -71.31 -1.59%
S&P 500 1,946.16 -26.13 -1.32%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

138.82 -1.64 (-1.17%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $138.82 -1.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $140.39
Previous Close $140.46
Daily Range $138.18 - $140.78
52-Week Range $105.76 - $144.46
Market Cap $105.4B
P/E Ratio 21.51
Dividend (Yield) $2.44 (1.7%)
Ex-Dividend Date
Dividend Pay Date
08/12/14
09/05/14
Volume 3,752,152
Average Daily Volume 2,847,537
Current FY EPS $8.24

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

3 Top Dividend Growth Stocks to Buy in October

Looking for income AND growth? Check these top picks out.

Amgen, Inc. Showing Strong Performance Despite Low Beta

Celgene Has A Very Bright Future Ahead

AMGN, ACT And GILD, Pushing Drugs Industry Downward

Notable ETF Inflow Detected - XLV, JNJ, AMGN, BMY

3 Likely Biotech Buyout Candidates

'Tax Inversions' Are Tip Of An Iceberg That Already Cost The U.S. Treasury Hundreds Of Billions

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog

'Fast Money' Recap: How to Trade After the Market's Drop

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog

BioMarin (BMRN) Faces Threat of Genericization for Kuvan - Analyst Blog

See More AMGN News...

AMGN's Top Competitors

AMGN $138.82 (-1.17%)
Current stock: AMGN
GILD $105.59 (-0.81%)
Current stock: GILD
CELG $93.43 (-1.42%)
Current stock: CELG
$0.00 (0.00%)
Current stock: